QUETIAPINE XR : Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)
Brand(s)
Summary
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
SIVEM PHARMACEUTICALS ULC |
QUETIAPINE XR/50MG |
DIN 02417359 |
Tablet |
QUETIAPINE (QUETIAPINE FUMARATE) 50 mg |
M2213000, M2213001, M2215146, M2214004, M2214005 |
SIVEM PHARMACEUTICALS ULC |
QUETIAPINE XR/150MG |
DIN 02417367 |
Tablet |
QUETIAPINE (QUETIAPINE FUMARATE) 150 mg |
M2214685, M2214686, M2214687 |
SIVEM PHARMACEUTICALS ULC |
QUETIAPINE XR/200MG |
DIN 02417375 |
Tablet |
QUETIAPINE (QUETIAPINE FUMARATE) 200 mg |
M2214012, M2214013, M2214014 |
SIVEM PHARMACEUTICALS ULC |
QUETIAPINE XR/300MG |
DIN 02417383 |
Tablet |
QUETIAPINE (QUETIAPINE FUMARATE) 300 mg |
M2214016, M2214017, M2214018 |
SIVEM PHARMACEUTICALS ULC |
QUETIAPINE XR/400MG |
DIN 02417391 |
Tablet |
QUETIAPINE (QUETIAPINE FUMARATE) 400 mg |
M2214020 |
Issue
Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP).
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
SIVEM PHARMACEUTICALS ULC
4705 Dobrin
Saint-Laurent, QC
H4R 2P7
Get notified
Receive emails about new and updated recall and safety alerts.